About the Company
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $FLXN News
Why Flexion Therapeutics (FLXN) Stock Is Plummeting in After-Hours Trading Today
Shares of Flexion Therapeutics (FLXN) plunged in after-hours trading Wednesday after the company announced the FDA placed a clinical hold on a Phase 2b trial of the company's osteoarthritis treatment.
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
The acquisition of Flexion Therapeutics, Inc. in November 2021 gave Pacira its second marketed product, Zilretta, which is indicated as the first and only extended-release, intra-articular therapy ...
Here's Why You Should Add Pacira (PCRX) Stock to Your Portfolio
Product Acquisitions Through Strategic Collaborations, a Positive: In April 2019, Pacira acquired the privately held company, MyoScience, Inc., following ... of Flexion Therapeutics for $8.50 ...
Versant Ventures III, LLC's Net Worth
Inc., and Flexion Therapeutics Inc. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive ...
EFTR eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product ...
Ovid Therapeutics Inc OVID
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
PFIZER INC's Net Worth
PFIZER INC has an estimated net worth of $2.44 Billion. This is based on reported shares across multiple companies, which include BioAtla, Inc., Viatris Inc, Cerevel Therapeutics Holdings, Inc ...
Kintara Therapeutics Inc KTRA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
ONTX Onconova Therapeutics, Inc.
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. It has two clinical-stage ...
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...
Dyne Therapeutics Inc
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases ...
Viking Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...